標(biāo)題: Titlebook: CADD and Informatics in Drug Discovery; Mithun Rudrapal,Johra Khan Book 2023 The Editor(s) (if applicable) and The Author(s), under exclus [打印本頁(yè)] 作者: Novice 時(shí)間: 2025-3-21 18:15
書(shū)目名稱(chēng)CADD and Informatics in Drug Discovery影響因子(影響力)
書(shū)目名稱(chēng)CADD and Informatics in Drug Discovery影響因子(影響力)學(xué)科排名
書(shū)目名稱(chēng)CADD and Informatics in Drug Discovery網(wǎng)絡(luò)公開(kāi)度
書(shū)目名稱(chēng)CADD and Informatics in Drug Discovery網(wǎng)絡(luò)公開(kāi)度學(xué)科排名
書(shū)目名稱(chēng)CADD and Informatics in Drug Discovery被引頻次
書(shū)目名稱(chēng)CADD and Informatics in Drug Discovery被引頻次學(xué)科排名
書(shū)目名稱(chēng)CADD and Informatics in Drug Discovery年度引用
書(shū)目名稱(chēng)CADD and Informatics in Drug Discovery年度引用學(xué)科排名
書(shū)目名稱(chēng)CADD and Informatics in Drug Discovery讀者反饋
書(shū)目名稱(chēng)CADD and Informatics in Drug Discovery讀者反饋學(xué)科排名
作者: reject 時(shí)間: 2025-3-21 20:49 作者: 小臼 時(shí)間: 2025-3-22 01:04
Informatics: Tools and Databases in Drug Discovery,herapeutic candidates. These details include information about pharmacological, general, biochemical, chemical, and physiological qualities. Today, the process of finding new drugs depends on being able to access and use vast amounts of data. These days, information is kept in databases, which are o作者: 背心 時(shí)間: 2025-3-22 08:22 作者: 和音 時(shí)間: 2025-3-22 11:26 作者: 不可侵犯 時(shí)間: 2025-3-22 16:35
Virtual Screening in Lead Discovery,sector. Computer-aided drug design (CADD) is a widely utilized technique to reduce the cost and time for the medication development process. Currently, it plays a significant role in the process of discovering and developing new drugs. Virtual screening is typically recognized as the best CADD techn作者: 不可侵犯 時(shí)間: 2025-3-22 17:44
Target-Based Screening for Lead Discovery, has become the dominant technique employed by numerous pharmaceutical businesses. However, despite increasing investment from pharmaceutical companies, the target-based drug discovery technique has not led to a concurrent increase in the number of unique molecular components or the identification o作者: 自愛(ài) 時(shí)間: 2025-3-23 00:15 作者: Digest 時(shí)間: 2025-3-23 01:54 作者: 浮雕 時(shí)間: 2025-3-23 07:55 作者: emulsify 時(shí)間: 2025-3-23 13:12 作者: FUME 時(shí)間: 2025-3-23 17:11 作者: bronchiole 時(shí)間: 2025-3-23 18:58 作者: 艱苦地移動(dòng) 時(shí)間: 2025-3-24 01:30
CADD Approaches in Anti-inflammatory Drug Discovery,, and infections have all been linked to excessive physiopathological damage. Anti-inflammatory drugs are used to treat inflammation symptoms, which mostly include pain, an increase in body temperature, flushing, and edema. It has been determined in this case to focus on prostaglandin E2 (PGE2) inhi作者: 外向者 時(shí)間: 2025-3-24 04:29 作者: ANTH 時(shí)間: 2025-3-24 09:21
,Das Erfolgsrezept Qualit?tsmanagement (QM),rugs, gives examples of how CADD has been used to screen target proteins, and talks about the general CADD procedures for both structure-based drug design and ligand-based drug design, with a focus on the strategies and targets that are commonly studied.作者: 夜晚 時(shí)間: 2025-3-24 11:56 作者: Fluctuate 時(shí)間: 2025-3-24 16:21 作者: Thyroid-Gland 時(shí)間: 2025-3-24 20:20
https://doi.org/10.1007/978-3-322-93682-0 Drug Discovery such as “Structure-Based Drug Design” (SBDD) and “Ligand-Based Computer-Aided Drug Design,” ADMET prediction in Computer-Aided Drug Design, and Molecular Dynamic simulation in Drug Discovery.作者: Manifest 時(shí)間: 2025-3-24 23:30 作者: panorama 時(shí)間: 2025-3-25 04:22 作者: 發(fā)芽 時(shí)間: 2025-3-25 07:49
https://doi.org/10.1007/3-211-37844-8DD) have been employed with effectiveness in the procedures of developing medications. This article presents a thorough analysis of structure-based drug design proposals for the creation of novel LOX inhibitors and COX inhibitors.作者: Genome 時(shí)間: 2025-3-25 11:52
Computational Modelling and Simulations in Drug Design, Drug Discovery such as “Structure-Based Drug Design” (SBDD) and “Ligand-Based Computer-Aided Drug Design,” ADMET prediction in Computer-Aided Drug Design, and Molecular Dynamic simulation in Drug Discovery.作者: 性學(xué)院 時(shí)間: 2025-3-25 18:36
Computational Methods in Natural Products-Based Drug Discovery,d associated challenges like database management. However, the advantages related to computational approaches might outweigh the risks. The NP-based drug discovery ought to have a vast future scope in the pipeline.作者: 租約 時(shí)間: 2025-3-25 22:46 作者: choleretic 時(shí)間: 2025-3-26 03:11
CADD Approaches in Anti-inflammatory Drug Discovery,DD) have been employed with effectiveness in the procedures of developing medications. This article presents a thorough analysis of structure-based drug design proposals for the creation of novel LOX inhibitors and COX inhibitors.作者: Distribution 時(shí)間: 2025-3-26 06:51 作者: 考古學(xué) 時(shí)間: 2025-3-26 09:53 作者: 事與愿違 時(shí)間: 2025-3-26 13:41 作者: 充氣球 時(shí)間: 2025-3-26 19:55
Role of Bioinformatics in Drug Design and Discovery,e and mining potential for these data for drugs, and points out some underlying restrictions inside the data and the programs used to mine them, indicating novel approaches to improve examination of these different information formats, highlighting popular libraries, and software that are pertinent 作者: HAIRY 時(shí)間: 2025-3-26 21:26
Informatics: Tools and Databases in Drug Discovery,search procedures. For the drug development process, there are several computer programs or tools with a wide range of applications, accuracy, and methodologies available on a global scale. For molecular modeling, docking, and protein conformation, ADMET predictions, pharmacophore mapping, visualiza作者: 酷熱 時(shí)間: 2025-3-27 04:14 作者: hypnogram 時(shí)間: 2025-3-27 05:18 作者: MAIZE 時(shí)間: 2025-3-27 12:08 作者: 抵押貸款 時(shí)間: 2025-3-27 16:23
Artificial Intelligence and Machine Learning in Drug Discovery,le of the AI/ML in the drug discovery process with the application and limitations and future approaches. We anticipate that as more scientists become aware of its potential, the usage of AI/ML in the drug discovery will continue to expand in the search of new drugs.作者: ANTE 時(shí)間: 2025-3-27 19:34 作者: 好開(kāi)玩笑 時(shí)間: 2025-3-28 00:35 作者: 代理人 時(shí)間: 2025-3-28 02:40
Drug Repurposing and Computational Drug Discovery for Viral Infections and COVID-19, host, protein-protein interaction of host, and the pathogen. This leads to a better treatment and also sets a platform to know further effects of drug in later stages as it can cause long-term effects. The drugs administered must be capable of inducing molecules like blocker that stops multiplicati作者: 水汽 時(shí)間: 2025-3-28 09:51 作者: 畢業(yè)典禮 時(shí)間: 2025-3-28 13:58 作者: 竊喜 時(shí)間: 2025-3-28 16:21
https://doi.org/10.1007/978-3-642-58653-8search procedures. For the drug development process, there are several computer programs or tools with a wide range of applications, accuracy, and methodologies available on a global scale. For molecular modeling, docking, and protein conformation, ADMET predictions, pharmacophore mapping, visualiza作者: majestic 時(shí)間: 2025-3-28 21:30 作者: 躺下殘殺 時(shí)間: 2025-3-29 02:08 作者: BRIEF 時(shí)間: 2025-3-29 05:56 作者: exostosis 時(shí)間: 2025-3-29 10:46 作者: 鴕鳥(niǎo) 時(shí)間: 2025-3-29 11:58
https://doi.org/10.1007/3-211-37844-8 be an effective alternate to the conventional drug discovery process. The traditional or de novo techniques of drug development are costly and time-consuming, and they do not always result in the discovery of new molecular entities (NME). Developing and identifying new rational uses for medicinal m作者: neolith 時(shí)間: 2025-3-29 17:30
Nachhaltige Entwicklung durch Qualit?tvelopment of new anticancer therapies by the merging of experimental and computational methodologies. By analyzing successful models from the literature, we want to present a holistic picture of the current status of computer-assisted anticancer drug development. The limits of each classic in silico作者: 運(yùn)氣 時(shí)間: 2025-3-29 22:51
,Führung — Management — Leitung, host, protein-protein interaction of host, and the pathogen. This leads to a better treatment and also sets a platform to know further effects of drug in later stages as it can cause long-term effects. The drugs administered must be capable of inducing molecules like blocker that stops multiplicati作者: floodgate 時(shí)間: 2025-3-30 01:47
2730-7069 rug design approaches (SBDD, LBDD, .de novo. drug design, pharmacophore-based search), bioinformatics tools and databases, computational screening and modeling of phytochemicals/natural products, artificial int978-981-99-1318-3978-981-99-1316-9Series ISSN 2730-7069 Series E-ISSN 2730-7077 作者: licence 時(shí)間: 2025-3-30 05:33
